News & Events
-
October 10, 2010
Manuscript on Current State of Pharmacometrics in Special Issue of Journal of Clinical Pharmacology Co-authored by C-Path’s Klaus Romero, MS, MD Recently Released
Pharmacometrics as a Discipline Is Entering the “Industrialization” Phase: Standards, Automation, Knowledge Sharing, and Training Are Critical for Future Success... -
October 10, 2010
Raymond Woosley, MD, PhD, C-Path President/CEO to present keynote address at CDISC North American Exchange November 1-5, 2010 in Baltimore, MD
The CDISC Board of Directors and Dr. Rebecca Kush, President & CEO are pleased to announce three exceptional keynote speakers to introduce this year’s event: Dr. Doug Fridsma, acting director of the Office of Interoperability and Standards in the Office of the National Coordinator for Health Information Technology; Dr. Theresa M. Mullin, Ph.D., Director, Office...... -
October 10, 2010
Governor Brewer Awards $2.2 Million in Stimulus Dollars Towards Creation of New Biomedical Research Resource in Arizona
Science Foundation Arizona selects Tucson based Critical Path Institute and collaborator, Roche’s Ventana Medical Systems, to develop innovative national resource for clinical research standardization... -
June 10, 2010
Coalition Against Major Diseases Introduces the First Combined Pharmaceutical Trial Data on Neuro-degenerative Diseases
A new database of more than 4,000 Alzheimer’s disease patients who have participated in 11 industry-sponsored clinical trials will be released today by the Coalition Against Major Diseases (CAMD).... -
June 10, 2010
Critical Path Institute’s Predictive Safety Testing Consortium Announces First-Ever Qualification Decision by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA).
For the first time, new biomarker tests to detect drug-induced kidney injury have been accepted by the Japanese Pharmaceuticals and Medical Devices Agency (PMDA)....